Skip to main content
Skip to main content
AQSP logo

Acquired Sales Corp. (AQSP)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Acquired Sales Corp. (AQSP) with AI Score 59/100 (Hold). Acquired Sales Corp. is currently exploring acquisitions in the cannabidiol (CBD) sector, transitioning from its previous focus on software and hardware. Market cap: 0, Sector: Consumer defensive.

Last analyzed: Mar 17, 2026
Acquired Sales Corp. is currently exploring acquisitions in the cannabidiol (CBD) sector, transitioning from its previous focus on software and hardware. The company aims to capitalize on the growing market for CBD-infused products.
59/100 AI Score

Acquired Sales Corp. (AQSP) Consumer Business Overview

CEOGerard M. Jacobs
Employees70
HeadquartersLake Forest, US
IPO Year2018

Acquired Sales Corp. (AQSP) is a holding company transitioning to the CBD market, exploring acquisitions of businesses involved in manufacturing and selling CBD-infused products. Previously focused on software, AQSP seeks to leverage the growing demand for CBD products within the consumer defensive sector.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 17, 2026

Investment Thesis

Acquired Sales Corp.'s investment thesis hinges on its successful transition into the CBD market through strategic acquisitions. The company's ability to identify and integrate profitable CBD businesses is crucial, given its current lack of significant operations. Key value drivers include the growth rate of the CBD market, which is projected to expand significantly over the next few years. Successful acquisitions could lead to substantial revenue growth and improved profitability. However, the company faces risks associated with regulatory uncertainty in the CBD industry and intense competition. The negative P/E ratio of -33.87 and a negative profit margin of -2.7% highlight the company's current financial challenges. The company's beta of -1.60 suggests it is less volatile than the market. The gross margin of 34.0% indicates potential for profitability if operations are scaled effectively.

Based on FMP financials and quantitative analysis

Key Highlights

  • Negative P/E ratio of -33.87 reflects current lack of profitability as the company transitions its business model.
  • Gross margin of 34.0% suggests potential for profitability in the CBD sector if acquisitions are successful.
  • Beta of -1.60 indicates lower volatility compared to the overall market.
  • Profit Margin of -2.7% reflects ongoing operational losses as the company explores new acquisitions.
  • No dividend yield reflects the company's current focus on reinvesting capital into strategic acquisitions.

Competitors & Peers

Strengths

  • Strategic shift towards the growing CBD market.
  • Potential for first-mover advantage in acquiring promising CBD businesses.
  • Experienced management team (if applicable to acquired businesses).
  • Established infrastructure (if applicable to acquired businesses).

Weaknesses

  • Lack of significant current operations.
  • Dependence on successful acquisitions.
  • Limited brand recognition in the CBD market.
  • Negative P/E ratio and profit margin.

Catalysts

  • Potential acquisitions of CBD businesses could drive revenue growth.
  • Increasing consumer demand for CBD products.
  • Regulatory developments in the CBD industry could create new opportunities.

Risks

  • Intense competition in the CBD market could limit market share.
  • Evolving regulatory landscape for CBD products creates uncertainty.
  • Dependence on successful acquisitions to execute business strategy.
  • Negative P/E ratio and profit margin reflect current financial challenges.
  • Fluctuations in raw material prices (hemp, CBD isolate).

Growth Opportunities

  • Expansion into New CBD Product Categories: AQSP can explore opportunities to expand its product offerings within the CBD market. This includes developing new formulations, delivery methods, and product categories to cater to diverse consumer preferences. The global CBD market is projected to reach billions of dollars in the coming years, offering significant growth potential for companies that can innovate and capture market share. Timeline: Ongoing.
  • Strategic Partnerships and Distribution Agreements: AQSP can pursue strategic partnerships with established retailers, distributors, and e-commerce platforms to expand its reach and market penetration. Collaborating with established players can provide access to existing customer bases and distribution networks, accelerating revenue growth. The market for CBD products is increasingly competitive, making strategic partnerships essential for success. Timeline: Ongoing.
  • Geographic Expansion: AQSP can explore opportunities to expand its operations into new geographic markets, both domestically and internationally. The demand for CBD products is growing globally, presenting opportunities to establish a presence in underserved markets. However, navigating regulatory differences across jurisdictions is crucial for successful geographic expansion. Timeline: 1-3 years.
  • Development of Proprietary CBD Formulations: Investing in research and development to create proprietary CBD formulations with enhanced efficacy and bioavailability can provide a competitive advantage. Differentiated products with unique benefits can command premium pricing and attract a loyal customer base. The market for innovative CBD products is expected to grow rapidly as consumers seek more effective solutions. Timeline: 2-5 years.
  • Acquisition of Complementary Businesses: AQSP can pursue acquisitions of complementary businesses within the CBD value chain, such as extraction facilities, testing laboratories, and marketing agencies. This can create synergies and enhance the company's overall capabilities. The consolidation of the CBD industry is expected to continue, presenting opportunities for strategic acquisitions. Timeline: Ongoing.

Opportunities

  • Expansion into new CBD product categories.
  • Strategic partnerships and distribution agreements.
  • Geographic expansion into new markets.
  • Development of proprietary CBD formulations.

Threats

  • Intense competition in the CBD market.
  • Evolving regulatory landscape for CBD products.
  • Potential for negative consumer perception of CBD.
  • Fluctuations in raw material prices (hemp, CBD isolate).

Competitive Advantages

  • First-mover advantage in acquiring promising CBD businesses (if successful).
  • Potential for brand recognition in the CBD market.
  • Proprietary CBD formulations (if developed).
  • Established distribution network (if acquired).

About AQSP

Founded in 1986 and headquartered in Lake Forest, Illinois, Acquired Sales Corp. (AQSP) initially operated in the software and hardware sectors, providing licenses, hardware, consulting, and maintenance services. Recognizing the evolving market landscape, AQSP has shifted its strategic focus towards the burgeoning cannabidiol (CBD) industry. Currently, the company does not have significant ongoing operations from its previous business model. AQSP is actively exploring potential acquisitions of operating businesses that manufacture and sell CBD-infused products. These products encompass a wide range, including beverages, muscle/joint rubs, oils, crystals, tinctures, bath bombs, isolate, relief balms, elixirs, body washes, med sticks, lotions, vape pens and cartridges, shatter, and gummies. This strategic pivot aims to capitalize on the increasing consumer demand for CBD products and establish a foothold in a rapidly expanding market. The company's future success hinges on its ability to identify and integrate suitable acquisition targets within the competitive CBD landscape.

What They Do

  • Currently exploring acquisitions in the CBD-infused products market.
  • Previously engaged in selling software licenses and hardware.
  • Offered consulting and maintenance services for software and hardware.
  • Aims to manufacture and sell CBD products like beverages and topicals.
  • Seeking to capitalize on the growing demand for CBD products.
  • Transitioning from a technology-focused business to a consumer-focused CBD business.

Business Model

  • Acquisition-based growth strategy focused on CBD companies.
  • Manufacturing and distribution of CBD-infused products.
  • Potential for online and retail sales channels.
  • Revenue generation through product sales.

Industry Context

Acquired Sales Corp. operates within the consumer defensive sector, specifically targeting the household and personal products industry through its planned entry into the CBD market. The CBD market is experiencing rapid growth, driven by increasing consumer awareness and acceptance of CBD products for various health and wellness applications. However, the industry is also characterized by intense competition and evolving regulatory landscapes. Companies like AIXN, EWOOF, HOJI, IDBHF, and LRKKF represent some of the competitors in the broader market. AQSP's success will depend on its ability to differentiate itself through product innovation, effective marketing, and strategic partnerships.

Key Customers

  • Consumers seeking CBD-infused products for health and wellness.
  • Retailers and distributors of CBD products.
  • Potential partnerships with health and wellness providers.
  • Online shoppers interested in CBD products.
AI Confidence: 71% Updated: Mar 17, 2026

Financials

Chart & Info

Acquired Sales Corp. (AQSP) stock price: Price data unavailable

Latest News

No recent news available for AQSP.

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AQSP.

Price Targets

Wall Street price target analysis for AQSP.

MoonshotScore

59/100

What does this score mean?

The MoonshotScore rates AQSP's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Gerard M. Jacobs

CEO

Gerard M. Jacobs serves as the CEO of Acquired Sales Corp. His background and experience prior to joining AQSP are not detailed in the provided information. As CEO, he is responsible for overseeing the company's strategic direction, particularly its transition into the CBD market. His leadership is crucial in identifying and executing successful acquisitions that align with the company's growth objectives. He manages 70 employees.

Track Record: Given the company's current state of transition, it is difficult to assess Gerard M. Jacobs' track record at Acquired Sales Corp. His success will be measured by his ability to navigate the complexities of the CBD market, integrate acquired businesses effectively, and drive revenue growth. The company's future performance will depend on his strategic decisions and execution capabilities.

AQSP OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Acquired Sales Corp. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, potentially increasing investment risk. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies often have less stringent listing requirements, resulting in a higher degree of speculative investment. Investors should exercise caution and conduct thorough due diligence before investing in OTC Other stocks.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Liquidity in OTC Other stocks like AQSP can be highly variable and often limited. Bid-ask spreads may be wide, and trading volume can be thin, making it difficult to buy or sell shares at desired prices. This lack of liquidity can increase price volatility and the risk of significant losses. Investors should be aware of the potential challenges in executing trades and managing their positions in AQSP due to its OTC listing.
OTC Risk Factors:
  • Limited financial disclosure due to OTC Other listing.
  • Thin trading volume and wide bid-ask spreads.
  • Higher price volatility compared to exchange-listed stocks.
  • Potential for delisting or trading suspensions.
  • Increased risk of fraud or manipulation.
Due Diligence Checklist:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's capital structure and debt levels.
  • Monitor trading volume and price volatility.
  • Consult with a financial advisor before investing.
  • Understand the risks associated with OTC investing.
Legitimacy Signals:
  • Company's stated business strategy of acquiring CBD businesses.
  • CEO's presence and management of 70 employees.
  • Company's history as a publicly traded entity (though transitioning its business).
  • Headquarters in Lake Forest, Illinois.

Acquired Sales Corp. Consumer Defensive Stock: Key Questions Answered

What does Acquired Sales Corp. do?

Acquired Sales Corp. is currently transitioning from its previous focus on software and hardware to the cannabidiol (CBD) market. The company is exploring potential acquisitions of operating businesses involved in the manufacture and sale of CBD-infused products, including beverages, topicals, and other CBD-based consumer goods. AQSP aims to capitalize on the growing demand for CBD products and establish a presence in this rapidly expanding market through strategic acquisitions and product development.

What do analysts say about AQSP stock?

As of 2026-03-17, there is no available analyst coverage or consensus on Acquired Sales Corp. (AQSP) stock. This is likely due to the company's small size, OTC listing, and ongoing business transition. Investors should conduct their own independent research and consider the risks associated with investing in a company with limited analyst coverage. Key valuation metrics, such as price targets and earnings estimates, are not currently available.

What are the main risks for AQSP?

Acquired Sales Corp. faces several key risks, including intense competition in the CBD market, evolving regulatory landscape for CBD products, dependence on successful acquisitions to execute its business strategy, and its current lack of significant operations. The company's negative P/E ratio and profit margin highlight its current financial challenges. Additionally, as an OTC-listed stock, AQSP is subject to higher price volatility and liquidity risks compared to exchange-listed stocks. Investors should carefully consider these risks before investing.

What are the key factors to evaluate for AQSP?

Acquired Sales Corp. (AQSP) currently holds an AI score of 59/100, indicating moderate score. Key strength: Strategic shift towards the growing CBD market. Primary risk to monitor: Intense competition in the CBD market could limit market share. This is not financial advice.

How frequently does AQSP data refresh on this page?

AQSP prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven AQSP's recent stock price performance?

Recent price movement in Acquired Sales Corp. (AQSP) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Strategic shift towards the growing CBD market. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider AQSP overvalued or undervalued right now?

Determining whether Acquired Sales Corp. (AQSP) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying AQSP?

Before investing in Acquired Sales Corp. (AQSP), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data as of 2026-03-17.
  • AI analysis pending for AQSP.
Data Sources

Popular Stocks